Invus Financial Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Taboola.com
TBLA
|
+$7.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
+$30.9M |
| 2 |
Coupang
CPNG
|
+$8.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.64% |
| 2 | Consumer Discretionary | 23.41% |
| 3 | Communication Services | 17.66% |
| 4 | Financials | 17.31% |
| 5 | Technology | 4.01% |
Similar funds
Invus Financial Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Invus Financial Advisors held 9 positions worth $154M, down 18% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Invus Financial Advisors withdrew a net $31.7M in Q1 2023, closing 1 position and reducing 1 holding. Its most notable exit was Oyster Point Pharma, Inc. Common Stock, an estimated $30.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Invus Financial Advisors added an estimated $7.25M to Taboola.com.
- Invus Financial Advisors added most to Taboola.com in Q1 2023, an estimated $7.25M increase.
- Invus Financial Advisors's biggest Q1 2023 reduction was Coupang, cutting an estimated $8.06M.
- Invus Financial Advisors fully exited Oyster Point Pharma, Inc. Common Stock in Q1 2023, selling an estimated $30.9M.
- Invus Financial Advisors's ten largest holdings make up 100% of its $154M portfolio in Q1 2023.
- Invus Financial Advisors opened 0 new positions and closed 1 in Q1 2023.
- Invus Financial Advisors's portfolio value fell 18% quarter-over-quarter to $154M.
Based on Invus Financial Advisors's 13F filing for Q1 2023, filed 15 May 2023.